|
| |
| |
|
|
|
|
|
|
|
|
| |
| |
| How can we enhance treatment precision in radiotherapy? |
| |
| At Amsterdam UMC the department of Radiation Oncology has installed 6 newly released ring-based linear accelerators (Varian, Ethos, Palo Alto) at locations in Amsterdam and at Flevoziekenhuis in Almere. These accelerators utilize the latest software, including artificial intelligence. With this design and this software, it is possible to adapt the treatment plan to the daily anatomy of the patient instead of applying the same plan every time. This technique is called online adaptive radiotherapy and it allows for a much more precise treatment which results in less radiation exposure of the healthy surrounding tissue.
|
| |
| Read more on our webpages |
| |
|
|
|
|
|
|
|
|
| |
| |
| Vote for the Cancer Center Amsterdam Awards |
| |
| The online voting for the Cancer Center Amsterdam (clinical and preclinical) publication award and the clinical/societal impact award is now open! Deadline: May 3rd, 2021. |
| |
| Vote! |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| Finding the right personalized treatment for patients with hereditary colon cancer |
| |
| Prof. Evelien Dekker and her team will investigate different methods of treatment and cancer surveillance for people with familial adenomatous polyposis (FAP). Left untreated, this hereditary condition inevitably leads to colon cancer. Their ultimate goal is to find the right surgical and endoscopic strategy for every single patient with FAP in order to prevent cancer, and to improve the quality of life for patients by reducing unnecessary treatments. |
| |
| More information about this project |
| |
|
|
|
|
|
|
|
| |
| |
| The hunt for new drugs to treat colon cancer peritoneal metastases |
| |
| Metastasis of colon cancer to the peritoneum, the membrane lining the abdomen, has a poor prognosis despite surgery and chemotherapy. Dr. Maarten Bijlsma has identified the molecular subtype of colon cancer that metastasizes to the peritoneum. In this project, his team will hunt for new effective chemotherapy drugs that exploit vulnerabilities of this subtype. |
| |
| More information about this project |
| |
|
|
|
|
|
|
|
| |
| |
| Helping frail patients with pancreatic cancer |
| |
| Pancreatic cancer is one of the most lethal cancers. For elderly or frail patients, surgery or chemotherapy is not an option, leaving only supportive care and symptom management. Dr. Anna Bruynzeel wants to improve outcome for this group of patients by testing if highly focused radiotherapy can improve survival and quality of life. |
| |
| More information about this project |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| Protein analysis to understand immune response regulation |
| |
| Former Spinoza winner Yvette Van Kooyk and colleagues used phosphoproteomics analysis to explore what kind of signaling pathways are activated after recognition of immune inhibiting glycans by dendritic cells. |
| |
| Read more on our webpages |
| |
|
|
|
|
|
|
| |
| |
| Emerging glyco-based strategies to steer immune responses |
| |
| A review in The FEBS journal highlights the emerging role of glycans in evoking or suppressing immune responses. Amsterdam UMC colleagues Fabrizio Chioda and Sandra van Vliet are co-authors on this review. |
| |
| Read more on our webpages |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| Cancer Center Amsterdam call 2021 |
| |
| The Cancer Center Amsterdam Call 2021 is now open for submission. One of the main goals this year is to stimulate early career researchers (<10 years post PhD) with highly innovative ideas. The proposed projects will be judged on potential and innovation and should not be ready to submit for funding elsewhere. Deadline for preproposals: June 1st, 2021. |
| |
| More information about this call |
| |
|
|
|
|
|
| |
| |
| Call for proposals by the Dutch Brain Tumor Foundation |
| |
| In 2021 Dutch Brain Tumor Foundation will be funding one or more research projects in the field of brain cancer immunology. The 2021 grant program of € 350,000 will open on March 22, 2021. From that date researchers – PI’s and Postdocs - in both Tumor-Immunology and Neuro-Oncology are invited to send in their applications – at first in the form of a pre-proposal. Deadline for handing in this information is May 7, 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| Call for proposals Lymph&Co Foundation |
| |
| The aim of this call is to fund groundbraking translational research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). The deadline for submitting the pre-proposals is on 8 June 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| NWO Talent Programme Vici awards |
| |
| These enable senior researchers to create their own research group, often in anticipation of a tenured professorship. Grants are worth up to € 1.5 million each over five years. Deadline for pre-proposals is 29 April, deadline for full proposals: 21 September 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| European Society for Medical Oncology - Travel grants – ESMO conference |
| |
| These support the attendance of individuals presenting abstracts at the ESMO conference, to be held from 16 to 21 September 2021. A limited number of awards are available and include conference registration and subsidized travel and accommodation. Deadline 5 May 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| NWO Rubicon grant |
| |
| These offer researchers who have completed their doctorates in the past year the chance to gain experience at a research institution outside of the Netherlands. The budget per round is € 2.28 million. Projects may last between one and two years. Deadline: 11 May 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| NWO Open science fund |
| |
| This supports researchers in developing, testing and implementing innovative ways of making research open, accessible, transparent and reusable. Grants are worth up to € 50,000 each for up to one year. Deadline: 18 May 2021. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| European Commission (EC) – Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship |
| |
| The MSCA Postdoctoral Fellowship (previously ‘Individual Fellowship’) under Horizon Europe will open mid-May. External deadline: 15 September. Changes from the H2020 programme can be found here. Research Grant Support (RGS) and the AMC Postdoc Network are organizing a Masterclass on 14 & 15 July from 9:00-10:30; please find more info and registration here. Internal support is available to fellows applying to join Amsterdam UMC (both AMC and VUmc locations) from abroad and for those applying for a Global Fellowship. |
| |
| Contact research grant support for more information |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| Course: Genetic engineering in model organisms |
| |
| This course (May 25-May 28) will show how CRISPR/Cas technology has revolutionized genetic engineering in animals, both in the germ line and in somatic tissue. The course will cover technology and applications of genetic engineering in basic and medical research. |
| |
| More information |
| |
|
|
|
|
|
| |
| |
| EUS (Endoscopic Ultrasonography) virtual live from Amsterdam |
| |
| 24th annual course - 11 June 2021 (13.00-17.40h). The program is designed for gastroenterologists, gastroenterologists-in-training, and nurses. |
| |
| More information |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| PhD defence V.P. Bastiaenen - April 16 |
| |
"A critical evaluation of diagnostic tools in abdominal surgery"
Reducing costs without compromising quality of healthcare is best achieved by replacing the one-size-fits-all approach by more risk-tailored diagnostic strategies. |
| |
| More info |
| |
|
|
|
|
|
|
|
| |
| |
| PhD defence S.C.J. Bosma - April 30 |
| |
| "Early stage breast cancer - Personalized radiotherapy in breast-conserving treatment" |
| |
| More info |
| |
|
|
|
|
|
|
|
| |
| |
| PhD defence A. Bongaarts - April 30 |
| |
| "Molecular features of low-grade developmental brain tumours: focusing on subependymal giant cell astrocytomas in tuberous sclerosis complex" |
| |
| More info |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
| Subscribe to our newsletter |
| |
| Professionals within Amsterdam UMC automatically receive this update on groundbreaking insights and developments in our research and treatments. Besides this, we give an overview of courses and PhD defences. Of course we want to share insights, only together we can beat cancer. Anyone outside can subscribe simple and for free. |
| |
| Subscribe |
| |
|
|
|
|
| |
| |
|
Science & Care connected
|
| |
| News you want to share? Mail to cca@amsterdamumc.nl
|
| |
| More information can be found on our webpages for professionals |
| |
|
|
| |
|
Change your preferences or unsubscribe from this newsletter.
|
| |
|
The information sent with this e-mail is exclusively intended for the addressee. Use of this information by anyone other than the addressee is prohibited. Disclosure, duplication, distribution and / or provision of this information to third parties is not permitted. The sender does not guarantee the correct and complete transmission of the content of a sent e-mail, nor the timely receipt thereof.
|
| |
|
|
|
